Your browser doesn't support javascript.
loading
Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions.
Wallis, Dylan J; Truong, Lisa; La Du, Jane; Tanguay, Robyn L; Reif, David M.
Afiliación
  • Wallis DJ; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA.
  • Truong L; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
  • La Du J; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
  • Tanguay RL; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
  • Reif DM; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA.
Toxics ; 9(4)2021 Apr 06.
Article en En | MEDLINE | ID: mdl-33917455
ABSTRACT
Exposure to endocrine-disrupting chemicals (EDCs) is linked to myriad disorders, characterized by the disruption of the complex endocrine signaling pathways that govern development, physiology, and even behavior across the entire body. The mechanisms of endocrine disruption involve a complex system of pathways that communicate across the body to stimulate specific receptors that bind DNA and regulate the expression of a suite of genes. These mechanisms, including gene regulation, DNA binding, and protein binding, can be tied to differences in individual susceptibility across a genetically diverse population. In this review, we posit that EDCs causing such differential responses may be identified by looking for a signal of population variability after exposure. We begin by summarizing how the biology of EDCs has implications for genetically diverse populations. We then describe how gene-environment interactions (GxE) across the complex pathways of endocrine signaling could lead to differences in susceptibility. We survey examples in the literature of individual susceptibility differences to EDCs, pointing to a need for research in this area, especially regarding the exceedingly complex thyroid pathway. Following a discussion of experimental designs to better identify and study GxE across EDCs, we present a case study of a high-throughput screening signal of putative GxE within known endocrine disruptors. We conclude with a call for further, deeper analysis of the EDCs, particularly the thyroid disruptors, to identify if these chemicals participate in GxE leading to differences in susceptibility.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Toxics Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Toxics Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos